Positive proof-of-concept clinical data show substantial improvements in visual acuity in limbal stem cell deficiency (LSCD) patients treated ...
Claris Bio has appointed veteran CEO Stephen Brady to lead advanced development of what it hopes to be the first drug therapy ...
A new biotech has come into view with a $118 million series B and a vision for making the front of the eye front-of-mind. | A new biotech has come into view with a $118 million series B and a vision ...
JERSEY CITY, N.J., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Claris Bio, a late-clinical stage biotechnology company focusing on corneal disease therapies, today unveiled the company and its lead program, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Apple spin-off Claris is launching a new entrepreneur training program in partnership with venture capital fund EonXI to improve diversity in technology. The new initiative will focus on low-code ...
In 1987, Apple moved its software products, such as MacPaint and the office suite AppleWorks, into a new subsidiary called Claris. But by 1998, most of Claris' products had either moved back to Apple ...
Low-code leader Claris announced a new initiative designed to increase diversity in technology and business ownership. The Low Code Accelerator program -- created in partnership with Black-led venture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results